General Information of Drug Transporter (DT)
DT ID DTD0017 Transporter Info
Gene Name ABCC6
Transporter Name Multidrug resistance-associated protein 6
Gene ID
368
UniProt ID
O95255
Post-Translational Modification of This DT
Overview of ABCC6 Modification Sites with Functional and Structural Information
Sequence
MAAPAEPCAG QGVWNQTEPE PAATSLLSLC FLRTAGVWVP PMYLWVLGPI YLLFIHHHGR 
GYLRMSPLFK AKMVLGFALI VLCTSSVAVA LWKIQQGTPE APEFLIHPTV WLTTMSFAVF 
LIHTERKKGV QSSGVLFGYW LLCFVLPATN AAQQASGAGF QSDPVRHLST YLCLSLVVAQ 
FVLSCLADQP PFFPEDPQQS NPCPETGAAF PSKATFWWVS GLVWRGYRRP LRPKDLWSLG 
RENSSEELVS RLEKEWMRNR SAARRHNKAI AFKRKGGSGM KAPETEPFLR QEGSQWRPLL 
KAIWQVFHST FLLGTLSLII SDVFRFTVPK LLSLFLEFIG DPKPPAWKGY LLAVLMFLSA 
CLQTLFEQQN MYRLKVLQMR LRSAITGLVY RKVLALSSGS RKASAVGDVV NLVSVDVQRL 
TESVLYLNGL WLPLVWIVVC FVYLWQLLGP SALTAIAVFL SLLPLNFFIS KKRNHHQEEQ 
MRQKDSRARL TSSILRNSKT IKFHGWEGAF LDRVLGIRGQ ELGALRTSGL LFSVSLVSFQ 
VSTFLVALVV FAVHTLVAEN AMNAEKAFVT LTVLNILNKA QAFLPFSIHS LVQARVSFDR 
LVTFLCLEEV DPGVVDSSSS GSAAGKDCIT IHSATFAWSQ ESPPCLHRIN LTVPQGCLLA 
VVGPVGAGKS SLLSALLGEL SKVEGFVSIE GAVAYVPQEA WVQNTSVVEN VCFGQELDPP 
WLERVLEACA LQPDVDSFPE GIHTSIGEQG MNLSGGQKQR LSLARAVYRK AAVYLLDDPL 
AALDAHVGQH VFNQVIGPGG LLQGTTRILV THALHILPQA DWIIVLANGA IAEMGSYQEL 
LQRKGALMCL LDQARQPGDR GEGETEPGTS TKDPRGTSAG RRPELRRERS IKSVPEKDRT 
TSEAQTEVPL DDPDRAGWPA GKDSIQYGRV KATVHLAYLR AVGTPLCLYA LFLFLCQQVA 
SFCRGYWLSL WADDPAVGGQ QTQAALRGGI FGLLGCLQAI GLFASMAAVL LGGARASRLL 
FQRLLWDVVR SPISFFERTP IGHLLNRFSK ETDTVDVDIP DKLRSLLMYA FGLLEVSLVV 
AVATPLATVA ILPLFLLYAG FQSLYVVSSC QLRRLESASY SSVCSHMAET FQGSTVVRAF 
RTQAPFVAQN NARVDESQRI SFPRLVADRW LAANVELLGN GLVFAAATCA VLSKAHLSAG 
LVGFSVSAAL QVTQTLQWVV RNWTDLENSI VSVERMQDYA WTPKEAPWRL PTCAAQPPWP 
QGGQIEFRDF GLRYRPELPL AVQGVSFKIH AGEKVGIVGR TGAGKSSLAS GLLRLQEAAE 
GGIWIDGVPI AHVGLHTLRS RISIIPQDPI LFPGSLRMNL DLLQEHSDEA IWAALETVQL 
KALVASLPGQ LQYKCADRGE DLSVGQKQLL CLARALLRKT QILILDEATA AVDPGTELQM 
QAMLGSWFAQ CTVLLIAHRL RSVMDCARVL VMDKGQVAES GSPAQLLAQK GLFYRLAQES 
GLV
PTM type
X-Acetylation X-N-glycosylation X-Phosphorylation X: Amino Acid

Acetylation

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCC6 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

254

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at ABCC6 Lysine 254 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCC6 [2]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

281

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at ABCC6 Lysine 281 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCC6 [3]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

15

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at ABCC6 Asparagine 15 has the potential to affect its expression or activity.

Phosphorylation

  Serine

        15 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCC6 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

238

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 238 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCC6 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

278

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 278 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCC6 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

294

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 294 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence ABCC6 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

492

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 492 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence ABCC6 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

493

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 493 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence ABCC6 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

681

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 681 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence ABCC6 [10] , [11]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

762

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 762 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence ABCC6 [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

878

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 878 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence ABCC6 [13]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

902

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 902 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence ABCC6 [14]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1229

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 1229 has the potential to affect its expression or activity.

  PTM Phenomenon 11

Have the potential to influence ABCC6 [14] , [15]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1232

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 1232 has the potential to affect its expression or activity.

  PTM Phenomenon 12

Have the potential to influence ABCC6 [16] , [17]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1286

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 1286 has the potential to affect its expression or activity.

  PTM Phenomenon 13

Have the potential to influence ABCC6 [9]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1310

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 1310 has the potential to affect its expression or activity.

  PTM Phenomenon 14

Have the potential to influence ABCC6 [18]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1446

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 1446 has the potential to affect its expression or activity.

  PTM Phenomenon 15

Have the potential to influence ABCC6 [19]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

1480

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Serine 1480 has the potential to affect its expression or activity.

  Threonine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence ABCC6 [19]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

491

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Threonine 491 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence ABCC6 [19]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

652

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Threonine 652 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence ABCC6 [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1135

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Threonine 1135 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence ABCC6 [14]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1224

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Threonine 1224 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence ABCC6 [20]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1252

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Threonine 1252 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence ABCC6 [18]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

1436

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at ABCC6 Threonine 1436 has the potential to affect its expression or activity.
References
1 Meningitis due to Streptococcus bovis biotype II. Clinical case and review of the literature. Enferm Infecc Microbiol Clin. 2002 Dec;20(10):537-8.
2 Comparison of contrast behavior of gadobenate-dimeglumine and Gd-DTPA in intra-axial brain tumors. A double-blind randomized intraindividual cross-over study. Radiologe. 2001 Dec;41(12):1063-71.
3 Subcellular localization and N-glycosylation of human ABCC6, expressed in MDCKII cells. Biochem Biophys Res Commun. 2003 Aug 22;308(2):263-9.
4 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5 Unusual Case of Combined Gliomeningeal Heterotopia on the Nose of an Infant. Am J Dermatopathol. 2018 Jul;40(7):515-518.
6 Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis. 2010 Mar;31(6):1080-9.
7 Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics. 2012 Sep;11(9):651-68.
8 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
9 Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
10 Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle. Hepatol Res. 2017 Dec;47(13):1469-1483.
11 Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma. Mol Cell Proteomics. 2014 Apr;13(4):1034-49.
12 Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013 Mar 26;6(268):rs6.
13 Phosphoproteome resource for systems biology research. Methods Mol Biol. 2011;694:307-22.
14 An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
15 Combined Quantification of the Global Proteome, Phosphoproteome, and Proteolytic Cleavage to Characterize Altered Platelet Functions in the Human Scott Syndrome. Mol Cell Proteomics. 2016 Oct;15(10):3154-3169.
16 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
17 Genetic heterogeneity of pseudoxanthoma elasticum: the Chinese signature profile of ABCC6 and ENPP1 mutations. J Invest Dermatol. 2015 May;135(5):1294-1302.
18 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
19 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: MRP6_HUMAN)
20 Health assessment of gasoline and fuel oxygenate vapors: micronucleus and sister chromatid exchange evaluations. Regul Toxicol Pharmacol. 2014 Nov;70(2 Suppl):S29-34.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.